Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Study findings could lead to less expensive and more effective cancer treatments

Study findings could lead to less expensive and more effective cancer treatments

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer

Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer

Simple molecular test may help predict presence of high-grade pancreatic cancers

Simple molecular test may help predict presence of high-grade pancreatic cancers

Fusobacterium may play role in colon cancer growth, study finds

Fusobacterium may play role in colon cancer growth, study finds

Specific protein negatively affects pancreatic cells and leads to cancer growth

Specific protein negatively affects pancreatic cells and leads to cancer growth

Chemotherapy-generated debris from dead and dying cancer cells can stimulate tumor growth

Chemotherapy-generated debris from dead and dying cancer cells can stimulate tumor growth

New targeted treatment could benefit patients with certain pancreatic tumors

New targeted treatment could benefit patients with certain pancreatic tumors

Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials

New mechanism in cancer cells to disarm attacking immune cells, study reveals

New mechanism in cancer cells to disarm attacking immune cells, study reveals

Study identifies substance released by pancreatic cancer cells to disarm attacking macrophages

Study identifies substance released by pancreatic cancer cells to disarm attacking macrophages

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FAIMS technology holds potential to be effective screening tool for pancreatic cancer

FAIMS technology holds potential to be effective screening tool for pancreatic cancer

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Four main genes linked to survival of pancreatic cancer patients

Four main genes linked to survival of pancreatic cancer patients

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

SU2C and its collaborators announce four teams to intercept cancer at earliest stages

Canadian and Israeli researchers join forces for new research program

Canadian and Israeli researchers join forces for new research program

UC San Diego Health scientists help create ‘dream team’ to prevent pancreatic cancer

UC San Diego Health scientists help create ‘dream team’ to prevent pancreatic cancer

Chinese scientists establish synthesis of promising compound to fight against pancreatic cancer

Chinese scientists establish synthesis of promising compound to fight against pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.